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ABSTRACT: 
 
 The protein B52 is an essential component of the spliceosome in Drosophila M. and is 
responsible for processing precursor-mRNA. B52 belongs to a family of proteins named SR 
proteins which are critical in initiation and commitment of RNA splicing. Analogous to human 
SRp55, B52 has been shown to be responsible for alternative and constitutive splicing during a 
multitude of cellular and developmental events. RNA aptamers selected during an in vitro 
selection and amplification process (SELEX) for B52 were found to have a co-variation in the 
stem of these aptamers. Using biochemical and structural techniques, I will explore the RNA-
protein interaction and discuss possible uses for future cancer treatments.   
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Electron micrograph and interpretative drawing of DNA 
template. The corresponding matured mRNA is shown in 
green as the ligated exons. Introns are 4-10 times more 
abundant then exons. 
 
Figure 1 
 
Fundamentals of Biochemistry  3rd Edition , Voet, pg. 967 
http://www.cbs.dtu.dk/staff/dave/roanoke/euk-splice.gif 
 
 
INTRODUCTION: 
 One of the most prominent post-transcriptional processes is mRNA splicing. The process 
has been proven to be a fundamental mechanism in possessing eukaryotic precursor transcripts 
(pre-mRNA) by excising out intervening sequences called introns and ligating together 
expressed sequences called exons. Appropriately named, the spliceosome is an ordered complex 
of protein and RNA that is responsible for the splicing process. The ability of eukaryotic genes to 
code for a vast number of proteins is rooted in the ability of the spliceosome to alternatively 
splice. Alternatively splicing is a method of splicing in which different combinations of exons 
are conjoined together allowing for a disproportionate number of proteins to be expressed 
compared to the number of genes. These alternatively spliced proteins are called isoforms in 
which many have similar function due to the similarity of their domains. The subsequent effect 
of producing a variety of proteins allows for its use as tissue specific and developmentally 
specific processes. Thus splicing must be strictly controlled in both time and space. This process 
is controlled by the numerous proteins that make up the spliceosome. The spliceosome is made 
up of small nuclear ribonucleoporteins (snRNPs) and non-snRNPs (Sharp 1994). The snRNPs 
are generally responsible for the specific recognition of splice sites. A family of non-snRNP 
proteins called SR proteins are serine-arginine rich and play a critical role in initiation and 
commitment of pre-mRNA splicing (Manley 1996). [Figure 1] 
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SR proteins contain at least one conserved region called RNA-recognition motifs (RRMs) 
at their N-terminus and a C-terminally located RS domain.  The RS domain contains arginine-
serine dipeptide repeats and is responsible for protein interactions, notably the ability to recruit 
snRNPs to the spliceosome, and both specific and general recognition of splice sites. SR proteins 
bind to exonic splicing enhancers/silences (ESEs/ESSs) on the exon which are typically 5 to 10 
nucleotides long. This binding is crucial in distinguishing from the longer intron sequences that 
may contain consensus sequences. The RRMs contain two highly conserved regions (RNP1 and 
RNP2) and have been proven to bind RNA with a high affinity. Drosophila SR proteins are 
evolutionary conserved and are analogous to seven human SR proteins: SRp20, SRp30a 
(SF2/ASF), SRp30b (SC35), SRp30c, SRp40, SRp55, and SRp75 (Zahler 1992). Most SR 
proteins are essential splicing factors and function in early spliceosome assembly (Manley 1996). 
SR proteins may seem redundant but it has been suggested that in alternative and constitutive 
splicing that SR proteins play an important role in specifying splice sites and can act distinctively 
in splicing (Zahler 1993).  
  B52 is a Drosophila SR protein analogous to human SRp55 and is lethal if deleted. 
These two analogous proteins, B52/SRp55, are transcribed from a single gene of a highly 
transcribed locus with chromosomal puffs (Fu 1995). Using increasing amounts of antibodies for 
B52’s RRM reduces both spliced products and splicing intermediates proving that B52 functions 
early in splicing activity. The induction of ftz transgene has shown that B52 depleted Drosophila 
were still able to splice normally past the second-instar larvae. It is known that other SR proteins 
are able to complement B52 deficient cells while no known mechanism is known at this time 
(Hoffman 2000). Pirior studies have proven the overlapping as well as specific function of SR 
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proteins, and specifically B52. A genetic screening for a second site enhancer of white apricot 
has shown a dominate mutant for the B52, proving its function is specific (Peng & Mount 1995). 
 Recent research has placed a special emphasis on the topic of mapping the splicing 
pathway in lieu of gene mapping. Out of the 13,472 genes in Drosophila M., 2,931were found to 
have evidence of alternative splicing. These genes generate 8,315 differently spliced mRNA and 
roughly that many isoforms. The development of a new Drosophila microarray platform has 
allowed for the identification of hundreds of distinct and complementary splice events. This 
newly developed microarray uses SL2 cells and a variable RNAi knockdown of splicing factors 
and high-level of analysis to give powerful data in a global perspective of Drosophila pre-mRNA 
splicing. Using these new methods it has been shown that B52/SRp55 and dASF/SF2 splicing 
events are similarly affected by the RNAi knockdown of either splicing factor for the same 22 
splicing events. While this does confuse the mapping of splicing pathways, the majority of B52 
splicing events were proven to strongly and consistently be affected by solely B52/SRp55 in 105 
specific targets. (Blanchette, 2005) Thus the characterization of B52’s RNA aptamers can be 
used to explain how the functional overlap may be due to unique pre-mRNA sites, similar 
binding specificities, or possible concomitant affects.  
Alternative research in the field of hnRNP’s (heterogeneous nuclear ribonucleoprotein) 
provides a reasonable source of cofounding information. The hnRNP family is a RNA-protein 
complex of the SR proteins involved in splicing as well as accompanying pre-mRNA from the 
gene to the nuclear pore. In particular, hrp45 is structurally similar to B52 but functions in an 
opposite manor by ensuring pre-mRNA splicing is complete prior to mRNA removal from the 
nucleus. Much like B52, hrp45 has been previously established as a splicing factor with 
differential substrate specificity as well as overlapping functions. (Alzhanova-Ericsson, 1996) It 
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has been found that hrp45 binds specifically to secretory protein gene transcripts and 
accompanies these products to nuclear pores. (Signh, 2006) The hrp45 has been found released 
in the nucleoplasm just prior to the unfolding and disassembly at the pore complex. (Alzhanova-
Ericsson, 1996) This field offers many leads and helps to advance the current studies of mapping 
gene products, characterizing SR proteins, and identifying the mechanism in which splicing 
occurs.  
 It has been established that the B52 protein is involved in eye development by alternative 
splicing of the eyeless gene. The gene is evolutionarily conserved and is essential in Drosophila 
eye development in Drosophila imaginal disc. B52 generates two isoforms of the eyeless protein 
by alternatively splicing a 60 amino-acid exon. The longer isoform is known as the “Ey” protein 
and can cause local eye over-growth, while the shorter “Ey(2a)” protein induces a small-eye 
phenotype.  It is believed that equal amounts of these proteins are required for normal eye 
development in the eye imaginal disc. In the absence of B52 protein, there is two fold decrease 
of Ey(2a) and two fold increase of Ey. Over-expression of B52 causes failure of the eye to form 
which is characteristic of mutant Ey gene. The mechanism of this process is still unknown but in 
vitro binding of B52 to exon 2 suggest its alterative splicing function (Fic 2007). 
 Not only does B52 play a fundamental role in Drosophila eye development but it has 
recently been discovered to regulate Drosophila cell cycle. The EF2 gene is generally considered 
a tumor suppressing gene and has two isoforms in Drosophila, de2F1 and de2F2 (Rasheva 2006). 
These two proteins seem to work antagonistically with de2F1 as an activator, and de2F2 as a 
repressor of S-phase entry and G1/S transcriptional program (Royzam 1997). When de2F1 is 
mutated the fly shows obvious growth retardation and cellular failure to enter S-phase, while 
de2F2 mutation has little effect. Interestingly and currently unexplainable is that when de2F1 is 
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mutated, de2F2 can rescue de2F1 to continue cell proliferation. Elimination of B52 causes a 
dramatic reduction of de2F2 proteins and activity of their target genes (likely de2F1). If B52 is 
eliminated and de2F1 is mutated, def2F2 proteins lose the ability to rescue de2F1. Insertion of 
intronless de2F2 in B52 deficient cells allows the rescue de2F1 and suggests that B52 acts as a 
splicing enhancer for de2F2’s repressive properties (Rasheva 2006). The idea that B52 protein is 
involved in the regulation of cell cycle increases its importance. 
 The implication to B52s possible use in cancer treatment has been recently exposed with 
studies on human SRp55. Fibroblast growth factor receptor 1 (FGFR1) gene has been proven to 
be alternatively spliced into two isoforms α-FGFR1 and β-FGFR1. These two isoforms differ in 
their extracellular domains with different ligand affinity and subsequent signal transduction 
pathways which are involved in embryo cell migration and cell proliferation.  The α-FGFR1 
isoform is found in normal human pancreatic and brain cells while malignancy of these cells has 
shown excess β-FGFR1production with the exclusion of one exon. Using glioblastoma cells it 
was was shown that two intron splicing silencers (ISSs) seem to contribute more to the inclusion 
of this exon then the ESS that controls normal inclusion of this exon in α-FGFR1. It has been 
observed that ESS mutations which reside next to ESE sequences can enhance SRp55 α-exon 
inclusion, while the transfection of a specific RNAi can reduce SRp55 production and 
subsequent inclusion of α-exon. This RNAi-mediated splicing of a specific exon is of great 
significance to these studies on B52 because the RNAi is classified as a short hairpin RNA 
interference (shRNAi) (Jin & Cote 2004). Besides the discovers of B52’s global function as a 
splicing factor or its use during development, B52 has been discovered to function as a eclectic 
protein within the nucleus. 
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 It has only recently been discovered in the past decade that splicing factors are involved 
in transportation of the processed m-RNA to the nuclear pore. Recent data has also shown that 
transcription speed can influence splicing of the transcript, and in a reciprocal manor, the 
splicing of the pre-mRNA can modulate transcription. Of particular surprise and importance was 
the discovery that B52 delivers DNA Topoisomerase I (Topo I) to RNA polymerase II-active 
loci. The study used a highly specific drug called camptothecin, which traps the enzyme Topo I 
once it has cleaved DNA. Topo I is responsible for relaxing the positive and negative 
supercoiling of DNA during transcription as well as the phosphorlyation of B52. The use of 
camptothecin results in inhibition of transcription, and prior inhibition had led to activation of 
promotor-promixal transcription. It was proven the B52 and Topo I colocalize along chromosal 
puffs in the nucleus by using Wee-P153 transgenic line that contains a GFP on the first intron of 
the top1 gene, and standard anti-B52 serum. The perfect overlay of B52 (red) and Topo1 (green) 
was then proven.  Researchers were able to create a transgene that made use of the UAS-BBS 
which expressed iaRNA (inhibitory aptamer RNA) with high affinity B52 Binding Sites. UAS-
BBS under heat shock promoter was shown to recruit B52 specifically to the transgene which 
was then shown to be accompanied by a GFP labeled Topo I.  (Juge, 2010) The importance of 
this discovery deeply broadens the scope of B52 manipulation. While there is little known about 
the mechanism, the data was collected in vivo and offers the possibility of an intermediate 
mechanism that could be used in future research. 
B52 contains two RRMs, a consensus RRM and a degenerate RRM along with a long RS 
domain that is typical of an SR protein. Using SELEX (Systematic Evolution of Ligand by 
Exponential Enrichment) a specific consensus nucleotide sequence was found to bind B52. 
SELEX is a process in which a large random pool of RNA is exposed to a target protein. The 
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Figure 2 
RNA is then eluted and amplified by PCR, this scheme is repeated while increasing the elution 
conditions until only the highest affinity ligands are left. These bound RNA ligands are called 
aptamers and while it is mostly unknown if they exist naturally they still exhibit high affinity to 
specific targets. [Figure 2] 
 
 
 
 
 
 
 
 
 
The aptamers for B52 were selected using a random 40 nucleotide regions flanked by 
primers to over 100 nucleotides and put through nine rounds of selection, creating 3.4 × 10
13
 
different sequences. Conveniently, the B52 Binding Sequences (BBS) were found to have a 
characteristic hairpin loop predicted by free energy minimization. [Figure 3a] Both of the RRMs 
of B52 are required for interaction with the BBS while the RS domain is not necessary. Only one 
RRM has a consensus structure with a compact βαββαβ structure which may bind single stranded 
RNA on surface of the four stranded β-sheet (Shi 1997). [Figure 3a & 3b] 
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 In search of transcripts in which B52 splices specifically for use in aptamer research, a 
representation of the Drosophila genome in 200-nt genomic sequences that bind B52 was in vitro 
selected and amplified. This process of searching for homologous probes to screen the genomic 
library used fewer PCR cycles and thermostable polymerase to reduce mutations. Of the 21 
isolated clones, 13 are known genes according to Flybase, and all but one are implicated to 
function in important cellular regulatory networks as opposed to transcription factors and/or 
Predicted secondary structures of B52 
Binding Sequences with the consensus 
motif in bold. 
Figure 3a 
Figure 3b 
Diagram of the B52 amino acid sequence 
broken down into distinct domains with 
their respective lengths. 
Shi, H. 1997 
Shi, H. 1997 
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signal transduction pathways. Interestingly, more than half of the 13 known genes contain 
matches in their intronic regions which is unexpected. Using B52 null-mutants stalled in the 
second instar-level of development, it was proven that B52 functions specifically in only 4 genes, 
while the others can be compensated with of SR proteins. It was unsuccessfully shown that the 
BBS aptamers selected for were faithfully present in these genes due to inability of suspected 
BBS-like regions to bind B52. This demonstrates SELEXs ability to evolve the highest affinity 
ligands without knowing if these sequences exist in vivo or will help to search known genomes. 
The process of in vitro selection and amplification seems ideal theoretically but one of the major 
draw backs is the evolution of undesired nonspecific ligands. The aptamers created for the 
targeted B52 were thought to be functionally the same and only structurally different. One family 
of aptamers called the Multi-G Motifs (MGMs) was thought to have been selected during 
“Systematic Evolution of Ligand by Exponential Enrichment” (SELEX) as a result of 
contamination because of their failure to bind the B52 protein (Shi 1997). [Figure 4] This family 
of aptamers was later proven to have been selected for by the nitrocellulose filter used in the 
SELEX partitioning step. The process of in vitro selection and amplification runs by the concepts 
of evolution and thus allowed MGMs to outcompete some of the desired family of aptamers 
called BBS. The BBS family of aptamers were the only RNA ligands proven to bind to splicing 
factor B52 (Shi 2002). The ability to reduce unwanted selection of aptamers was made possible 
by involving specific ribonuclease digestion which was proven effective against MGMs.  
  
  
 
 
Figure 4 
2.5% Agarose EMSA to test the affinity of 
sequences competing for B52 in 20-uL 
reactions. 
Shi, H. 1997 
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The subsequent aptamers being selected for gave a clearer outline of the BBS family. 
Deletion and substitution mutations defined B52-binding site on these RNA as a hairpin loop 
structure covering 20 nucleotides, which was confirmed by structure specific enzymatic probing. 
When the bulge in BBS#8 was deleted (U bulge), the binding activity wasn’t compromised, and 
an additional third BBS was found to bind B52. The most conserved sequence resides in the stem 
but the loop is also critical for creating the protein-RNA interaction. A core 17-nt BBS of RNA 
has been established. Using enzymatic probing of bound RNA allowed for a specific 
identification of the protected nucleotides and confirmed the predicted BBS. These tests 
confirmed the primary sequence and secondary structure of the RNA. 
 It has been estimated that 15% of human genetic diseases result from mutations in pre-
mRNA splicing defects and that altered levels of alternatively spliced proteins correlate to tumor 
progression (Voet, Voet, & Pratt 2008). These facts have been proven for B52’s analogous SR 
protein (SRp55) in FGFR1 alternative splicing. The significance of studying this RNA-protein 
interaction has become enhanced with the use of shRNAi which has been proven to show 
specific and efficient control of in vivo splicing. Studying the structural interaction between B52 
and its aptamers may provide further insight into B52’s splicing mechanism in numerous cell 
activities. The ability to create RNA aptamers with high affinity and specification towards B52 
lends its possibility towards therapeutic use in cancer. 
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MATERIALS AND METHODS: 
 
In vitro Large-Scale RNA Transcription and Purification 
 The oligonucleotides were ordered from Integrated DNA Technologies, Inc. The DNA 
template has only 2 cytosine base pairs added to increase stability, and provide a structurally 
convenient hairpin loop. The concentration of the DNA was measured using a UV/VIS 
spectrometer. The actual concentration was 100nM less than requested which is to be expected. 
A T7 promoter strand “T7 Top” was annealed to the DNA in an equimolar ratio by combing 
50µM of each and adding water to reach the final volume. Reaction was allowed to anneal at 
95°C for 3 minutes.  
 Prior to running large scale, a small scale optimization transcription was run, and the 
subsequent parameters were used in large scale. Large scale transcription was conducted by 
reacting each 100mM NTPs, 100mM DTT, 1X Transcription Buffer (400mM Tris-HCl pH 8.0, 
10mM spermidine, .1% (v/v) Triton X-100), 1M MgCl2, 50µM Annealed DNA stock, T7 RNA 
Polymerase, and water for six hours in a 37°C incubator. After six hours the reaction mix was 
spun for 5 minutes at 4,000 rpm and the supernatant was collected. Added 1/10 volume of 0.5M 
EDTA pH8.0, and 2.5-3X volume of cold 100% ethanol to supernatant. The first centrifuge is to 
remove the magnesium pyrophosphate. The EDTA will chelate the remaining Mg and the 100% 
ethanol to precipitate the RNA in -20°C freezer overnight. 
 Centrifuge the RNA mixture at 12,000 rpm for 45 minutes. Dry the pellet out under the 
hood for 2 hours, then resuspend pellet in denaturing nucleic acid polyacrylamide gel loading 
buffer (80%  (v/v) formamide, 10mM EDTA pH8.0, 0.25% (w/v) bromophenol blue, and 0.25% 
(w/v) xylene cyanol).  Each RNA was loaded onto its own denaturing polyacrylamide gel (20% 
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Acrylamide:10% APS:TEMED in at 1:100:1000 ratio). Use 1X Tris-Borate-EDTA buffer and set 
power supply to 25 Watts/gel for 20 hours. The gel took 1 hour to cool, and extensive cleaning of 
the wells was used as a precaution against contamination. Place the gel on TLC plates which 
allows visualization of the RNA under short wavelength UV light. The UV shadow was cut out 
and placed in an electroelution setup called Elutrap, using BT1 and BT2 membranes and 1X 
Tris-Borate-EDTA buffer. Fractions were collected every 3 hours at 150 volts.  
 For purification an anion exchange column with DEAE-resin was used. The column resin 
is positively charged and binds to the negatively charged RNA, which can then be eluted off with 
high salt buffers which have a higher ionic strength. The purified RNA was then stored in 2.5-3X 
100% ethanol to precipitate the RNA. The final yield of transcripts was 260nmole, 114nmole, 
and 281nmole of purified AA, AAU, and GC respectively 
 
B52 Protein expression and purification 
 Escherichia Coli BL21 cells were used to transform with a plasmid encoding the genes 
for the expression of a histidine tagged B52-RRM12. Over-expression of protein in bacterial 
cells is a simple and efficient way to produce high concentration protein. The DNA plasmid was 
added to cells and heat shocked for 30 seconds at exactly 42°C. After cooling for 2 minutes, 
250ul of SOC solution was added and cells were incubated for 1 hour at 37°C shaking at 250 
rpm. The cells were spread on Agar plates (Ampicillin and Chloramphenicol) and placed in 37°C 
incubation overnight.  
 The culture was scraped into an LB Broth (containing Ampicillin and Chloramphenicol) 
and incubated at 37°C for 16 hours. The overnight culture was then used to inoculate LB Broth 
at 37°C shaking at 225 rpm while the OD (optical density) was measured every hour. Once the 
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OD reached 0.8 the bacteria were induced with IPTG to 1mM, incubated at 37°C for four hours, 
and then spun down to pellets which were stored at -20°C. The pellets were resuspended in 5mL 
of denature lysis / binding buffer ( 100mM NaH2PO4, 10mM Tris base, 8M urea pH 8.0) for 
every gram of pellet. The pellets were sonicated (Amplitude 45%, Pulse on .3 sec, Pulse off 1 
sec) to lyse the cell and allow the protein into solution. The cellular debris were collected by 
centrifuge at 10,000 rpm for 25 minutes.  
 The protein was then run in a Nickel column in 4°C. Refolding buffers with a decreasing 
amount of urea were used to refold the protein and then the protein was eluted out with 500mM 
imidazole which outcompetes Histidine for Nickel binding.  A Sodium-Dodecyl-Sulfate poly 
acrylamide gel electrophoresis (SDS-PAGE) was run in order to analyze the purity of the 
fractions and appropriate size of approximately 26 kDa. The protein was dialysized for two hours 
into a protein buffer (20mM Tris(hydroxymethyl)aminomethane, 200mM NaCl, 2mM DTT, 
15% Glycerol, and 1mM PMSF) using spectrapore membrane tubing with cutoff MW of 12,000-
14,000. The fractions were then pooled together and concentrated down using Amicon Ultra 
Centrifugal Filter Device. The concentration of the protein was determined using the SDS-PAGE 
with known amounts of BSA to visually approximate band strength. 
 
RNA-Protein Binding Reaction 
 To test the binding efficiency 
32
P-labeled RNA were probed against different 
concentrations of B52 protein. The template oligonucleotides were ordered from Integrated DNA 
Technology with a T7 promoter sequences incorporated and an additional three cytosine dNTPs 
at the first three transcription positions to increase stability of the molecule and thus increase 
transcription efficiency. Each template was made into 1mM stock solutions with DEPC treated 
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H20 and stored at -20°C.  The DNA templates were annealed to 1mM of T7 top at 95°C for 3 
minutes to create a 50uM annealed stock. The 50uM annealed stock was then primer extended on 
a thermal cycler (denatured at 95°C for 5 minutes, annealed at 62°C for 10 minutes, and 
extended at 72°C for 30 minutes) with elevated temperatures due to the high Tm of the 
oligonucleotides. The RNA was uniformly labeled with [α-32P] ATP by using T7 MAXIScript in 
vitro transcription kit according to the manufacturer’s instructions. To test the presence and 
purity of the 
32
P-RNA a 20% denaturing gel (20% acrylamide (30:1 acrylamide:bisacrylamide), 
1X Tris-Borate-EDTA, 7M urea, 10% APS, TEMED) was run at 200 volts for 35 minutes. The 
RNA was reconstituted in 1x Binding Buffer (50mM Tris-Cl, pH7.6, 200mM KoAc, 5mM 
MgCl2, 2.5mM DTT) containing approximately 25fmol of each probe. The binding reaction 
typically used 0 to 20 pmole of truncated B52 protein to allow stoichiometric visualization of the 
binding. Besides the protein-RNA complex and binding buffer the reaction contained BSA 
(5mg/mL), and Yeast RNA (5mg/mL) which were incubated at 37°C for 45 minutes.  
 
Agarose EMSA and Filter Binding 
 The standard 20µL binding reactions were loaded with 20% glycerol onto a 2.5% 
Agarose gel with 0.25% Tris-Borate-EDTA buffer at 100 volts in 4°C. The gel was dried on 
Whatman paper and DEAE (Whatman DE81) at 50°C for 2 hours. The gel was then exposed to a 
phosphoimaging screen for 5 to 10 minutes and read by a Storm 860 scanner. 
 Nitrocellulose binding and immobilization paper was obtained from Schleicher and 
Schuell with a 0.45 µm pore size. The nitrocellulose filter paper was placed in the filter binding 
apparatus with slit-blot top and washed with 200 µL of 1x binding buffer prior to loading 
reactions.  Immediately after loading the 20 µL binding reactions onto the membrane, the wells 
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were washed with an additional 1 mL of binding buffer to reduce nonspecific background 
retention. The nitrocellulose paper was then exposed to a phosphoimaging screen for 5 to 10 
minutes and read by a Storm 860 scanner. 
 
UV Melting Analysis 
 UV melting was obtained using a Cary 300 Scan UV-Visible Spectrophotometer of five 
different sample. The RNA aptamers from the large scale transcription were each tested with five 
samples of vary amount of NaCl concentration from 50mM to 1 M (10mM 3-(N-
morpholino)propanesulfonic acid pH 7, and 5µM RNA). This variation in ion concentration 
allows determination of the range in which the transitions are visible under. The samples were 
annealed at 65°C for 10 min and then cooled to room temperature before being placed in 
spectrophotometer. The use of blank samples and a temperature control were used to provide 
baseline readings. 
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RESULTS AND DISCUSSION: 
 
Co-Variation 
 The evaluation of BBS aptamers confirmed the 17-mer consensus region that makes up a 
hairpin loop but also revealed variation within this conservative region. The positions of 2, 9, and 
16 seem to vary among the BBS family while the other positions are highly conserved (Shi 
2002). There are three different RNA’s that bind with equal affinity to BBS: a 22-mer B52GC, a 
23-mer B52UGC, and a 24-mer B52AA. The particular positions of #2 and #16 are of special 
interest because they reside in the stable stem structure forming a co-variation. [Figure 5] One of 
the base pair combinations is theoretically a non-Watson-Crick base pair A-A, while the other is 
a typical Watson-Crick G-C. The A-A variant forms an internal loop with unpaired bases (A-C 
and G-A) which may due to some structural change that compensates for this entropically 
unfavored secondary structure, making the BBS variations isosteric. The UG-C variant was the 
other aptamer synthesized with a U bulge and further investigation showed that the U bulge can 
be removed to still produce active binding with B52, called the GC variant. These two variants 
(UGC and AA) were shown to evolve in equal frequency and can compete equally well for B52 
binding (Kim et al, NAR 31:1955). With the BBS family well defined we were able to test these 
minimal aptamer stem-loops towards B52 binding. These three co-variants all compete equally 
well for B52 binding. The reason for this is unknown and we hope to uncover the answer through 
studying the structure of these aptamers. 
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Agarose EMSA 
 This past academic year I have successfully expressed and purified the His-Tagged B52-
RRM12 construct and prepared radiolabeled RNA probes, including the original aptamer and 
three short derivatives. [Figures 6,7, & 8] However, thus far there has been very little success 
with visualizing the binding reaction. [Figure 8] 
32
P –Labeled BBS#8 and over expression of the 
B52-RRM12 protein have been shown to successfully replicate the positive control in filter 
binding. Due to trouble transcribing the labeled RNA, additional G base pairs was added to the 
stem of each aptamer co-variant. The shift will hopefully show the ability of the co-variants to 
bind equally efficient compared to each other as well as compared to the BBS#8. The use of 
filter binding will provide an outline for binding efficiency which will then be quantified on an 
Agarose EMSA. This will be measured in the dissociation constant (Kd) which measures the 
complexs ability to fall apart into complement molecules. Using an excess amount of protein 
compared to RNA allows for a calculation which negates the difference between free and total 
protein. Since the RNA is radiolabelled, it can provide visualization of the RNA-Protein complex 
Figure 5 
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which can then be subtracted from total RNA to calculate free RNA. With at least a 100 fold 
excess of protein, the Kd can calculated with equation 1. 
 
 
 
 
 
                                   
 
Figure 6 Figure 7 
SDS-PAGE of increasing concentrations of BSA 
(1µg, 5µg, 10µg, and 20µg) against purified B52 
protein to approximate its concentration. 
 [Protein]total[RNA]free 
     [Protein-RNA] 
Kd  =  =     [Protein]total 
       [RNA]free 
  [Protein-RNA] 
Equation 1 
Figure 8 
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 It is extremely unlikely that the binding doesn’t occur considering that the co-variants 
contain the active stem loop region which is further stabilized by G-C pairs, and the truncated 
B52 protein has already been shown to bind the original aptamer with high affinity. The failure 
of the shift assay is possibly due to dissociation of the B52 protein-RNA complex on the gel. To 
ensure that the protein remains active, further precautions can be made to keep the temperature 
low during purification and EMSA. To check for RNA contamination and correct transcription 
the RNA preparation can be run on a larger 20% polyacrylamide-7M urea gel. The gel will give 
a better approximation of the RNA concentration as well as check the size of the transcribed 
RNA. [Figure 9a &9b]                               
 
 
 
 
 
 
\ 
 
 
 
Structural Analysis 
 Heating and Cooling of RNA under quasi-stationary conditions the RNA can be unfolded 
from their native disordered state into an ordered folding when cooled. The temperature at the 
midpoint of this transition is termed Tm. The hypochromicity of stacked bases provides an 
Figure 9a 
Figure 9b 
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extremely sensitive to UV absorbance at 260nm and 280nm. Uses two wavelengths allows for 
the minimal number of transitions to be viewed. If the derivative of absorbance relative to 
temperature is plotted (dA/dT) is plotted, corresponding peaks represent partial transitions in the 
RNA folding. Lower peaks typical represent tertiary unfolding (pseudoknots, water bridges, and 
canonical base pairs) while higher temperature peaks represent more stable bases (bulges, loops, 
hairpins, and junctions). The ΔS and ΔG can be tabulated and using the nearest neighbor model 
for Watson-Crick and non-Watson-Crick basepairs. The ΔH and ΔG can be predicted and fitted 
to create the theoretical curve to coincide the observed curve. At this point in time the data from 
UV melting is being tabulated and fit for the three minimal stem-loop structures. 
 The use of NMR spectroscopy will allow for observation of resonating protons in a 
magnetic field. The presence of imino protons (N-H) on the purine’s, Guanine and Uracil, 
produce characteristic chemical shifts that are useful in NMR structural studies. These shifts can 
be used to indicate Watson-Crick base pairs through interaction with other imino protons. Due to 
the fact that Watson-Crick base pairs of G-C and A-U each have an imino proton, there will 
typically be a peak for each base pairs. Once the 2D NMR data has been collected it can be 
analyzed for non Watson-Crick base pairs, and to prove that the aptamer sequences are 
representative of the predicted secondary structure. To conduct the spectroscopy takes a 
considerable amount of RNA, at least 100nmoles, after which 3D NMR spectroscopy can be 
conducted to determine tertiary structure to determine the exact position of each nucleotide.  At 
this point in time the RNA is being purified and concentrated to be run on NMR and will provide 
further insight into the structure of these three aptamers. 
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Figure 10 
Purposed Structure 
 There have been recent structurally studies on similar motifs which also contain a 
conserved sequence and internal loop structures. A very similar aptamer that was also 
synthesized used SELEX is a nucleolin-recognition element (NRE) which is recognized by the 
two RRMs of nucleolin. Nucleolin is a nucleolar phosphoprotein involved in the maturation of 
ribosomes. The NRE makes up a core 18-nt flexible stem-loop structure with its stem containing 
a loop E motif and its loop able to exchange between differing conformations. This equilibrium 
between the stem and loop is unique among RNA-protein complexes and increases the 
possibility of discovering a novel binding interaction between BBS-B52. The use of NMR 
allowed a purposed RNA to adopt a loop E motif, with an S-turn backbone, as well as the 2 
RRMs surrounding the NRE aptamer. (Bouvet 2001) [Figure 10] 
 
  
 
 
 
 
 
 
 
Similar studies have been conducted with homologs to SR proteins in yeast, such as 
NpI3, a family of RNA-binding proteins that protect proper transcription. Recent research has 
discovered the structure of NpI3’s interaction with RNA is able to balance transcription and 
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termination through the use of NpI3’s two RRMs. It was concluded that NpI3 bound in a similar 
fashion that NRE does and was supported with NMR data showing that the two RRM domains 
do not interact with each other in RNA-free form, while the linker region becomes ordered in 
concomitant with the rest of the complex. A major and significant difference with NpI3 is that it 
appears to have a 5:1 stoichiometry difference between RRM2 and RRM1 affinity. While these 
sequences recognize G+U rich oligionucleotides the NMR data proves RRM-2 to form a much 
stronger interaction. (Deka, 2007) While NpI3 protein doesn’t have sequence specific binding of 
its RRMs like B52 does, it opens a possibility for the B52-RNA interaction. It is possible that 
one of B52’s RRMs recognizes the specific RNA consensus sequence with a much higher 
affinity then would be need to recruit other proteins to the splice site.  
 29 
CONCLUSION: 
The research conducted in the field of splicing factors has been growing exponentially 
over the past decade. Of which, SR protein B52 and its homolog SRp55, seem to be showing the 
most promise in their multitude of cellular events. B52 has been proven to be critical in: 
alternative and constitutive splicing, overlapping and specific splicing, eye development, cell 
cycle check points, splicing in cancer cells, packaging of mRNA, and delivery of Topo I. The 
protein B52 sits in the middle of a tangled mechanism which holds the key to future cancer 
therapy and understanding gene products. While this thesis provides a good ground to which B52 
can be further explored, the full characterization of B52 will soon be needed. 
With great expertise in this area I would suggest future research towards applied gene 
therapy using RNA aptamers. It has been stated that B52 associates with chromosomal puffs and 
is a known essential component of transcription. Since B52 is more prominent in developing 
cells and is concurrently being mapping in a specific and systematic way in relation to specific 
genes, a climatic point is being reached. I would suggest the development of a multi-valent 
aptamer that is capable of recognizing B52 activation in stem-cell niches that are undergoing 
cancerous chromosomal puffs. This development is only years away and the methods that make 
this feasible have only recently been implemented. The creation of a tetravalent aptabody that 
can recognize two B52 proteins is a great starting point and offers promise to this study. (Xu,  
2009) With a myriad of advantages over protein/antibody use in therapeutic cancer treatment, 
RNA aptamers selected to control splicing proteins, and in particular B52, should begin to 
become a more plausible intervention over the decades to come. 
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